Details are being revealed concerning the failure of federal public health officials about lingering safety issues with the COVID-19 vaccine.

FairJourney Bio (FJBio), a global antibody discovery contract research organization (CRO), today announced the opening of its advanced cryo-electron microscopy (cryo-EM) structural biology facility in ...

A public health expert breaks down the details of the CDC delaying reporting of COVID-19 vaccine benefits, including study ...

Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of ...

Dr. Jay Bhattacharya objected to the study’s methodology, saying it gave an inaccurate picture of the vaccine’s benefits.

The acting CDC director cited concerns with the methodology, but the design has long been used to test vaccine effectiveness.

Amid growing financial concerns and US vaccine hesitancy, the German company will close its mRNA site in Southeast Asia.

Shah Capital, which has agitated for change at the vaccine maker for years, is calling on fellow shareholders to end what it ...

Katalin Karikó, a Nobel Prize-winning scientist who pioneered mRNA research that led to life-saving vaccines during the COVID ...

"Your tenure has overseen a DESTRUCTION of shareholder value—a direct result of chronic operational shortcomings and failures ...

A pivotal clinical trial has been terminated prematurely, marking a significant setback for Pfizer and BioNTech. Their large U.S. study for the COVID-19 vaccine ...

It turns out that Tweeting about RCTs 100+ times is a lot easier than delivering even a single RCT.